Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
News

Melissa Etheridge Blasts Angelina Jolie for Choosing Preventive Breast Cancer Surgery

The debate over Angelina Jolie’s decision to have a double mastectomy in order to reduce her chances of breast cancer from a ‘Jewish gene’ mutation just got feisty.

Singer-songwriter Melissa Etheridge, who is herself a breast cancer survivor, said Jolie’s decision was “fearful”, in an interview with the Washington Blade. Asked about Jolie’s decisions, Etheridge, 52, said she would encourage people to wait a lot longer before deciding on a mastectomy.

“I have that gene mutation too and (preventive mastectomy) is not something I would believe in for myself,” Etheridge said. “I wouldn’t call it the brave choice. I actually think it’s the most fearful choice you can make when confronting anything with cancer.”

Jolie has yet to respond to Etheridge’s comment. Her husband, Brad Pitt, who invited Etheridge perform in his wedding ceremony to Jennifer Aniston, his previous wife, seemed to be surprised by the statement.

“Melissa’s an old friend of mine,” Pitt told US Magazine during a June 17 red carpet event in New York City. “I’m sure we’ll talk on the phone.”

The celebrity feud comes on the heels of groundbreaking and long awaited Supreme Court decision, ruling that human DNA cannot be patented without being altered in some way.

The decision is a victory for people who carry the BRCA mutation, like Jolie and Etheridge, because pace of research of the genetic mutation is now expected to accelerate significantly.

BRCA1 and BRCA2 are two genes that are linked to breast and ovarian cancer. Ashkenazi Jews are much more likely to carry the BRCA mutation than the general population.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse..

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.